DK0785787T3 - Anvendelse af 1,5-benzodiazepinderivater til kontrol af mavetømning hos patienter med ikke insulinafhængig diabetes mellitus - Google Patents

Anvendelse af 1,5-benzodiazepinderivater til kontrol af mavetømning hos patienter med ikke insulinafhængig diabetes mellitus

Info

Publication number
DK0785787T3
DK0785787T3 DK95935280T DK95935280T DK0785787T3 DK 0785787 T3 DK0785787 T3 DK 0785787T3 DK 95935280 T DK95935280 T DK 95935280T DK 95935280 T DK95935280 T DK 95935280T DK 0785787 T3 DK0785787 T3 DK 0785787T3
Authority
DK
Denmark
Prior art keywords
insulin
patients
diabetes mellitus
dependent diabetes
gastric emptying
Prior art date
Application number
DK95935280T
Other languages
English (en)
Inventor
Rochelle Hanley
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Application granted granted Critical
Publication of DK0785787T3 publication Critical patent/DK0785787T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
DK95935280T 1994-10-14 1995-10-13 Anvendelse af 1,5-benzodiazepinderivater til kontrol af mavetømning hos patienter med ikke insulinafhængig diabetes mellitus DK0785787T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9420747A GB9420747D0 (en) 1994-10-14 1994-10-14 1,5 benzodiazepine derivatives
PCT/US1995/012830 WO1996011691A1 (en) 1994-10-14 1995-10-13 Use of 1,5-benzodiazepine derivatives for the control of gastric emptying in patients with non-insulin dependent diabetes mellitus

Publications (1)

Publication Number Publication Date
DK0785787T3 true DK0785787T3 (da) 2002-03-11

Family

ID=10762854

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95935280T DK0785787T3 (da) 1994-10-14 1995-10-13 Anvendelse af 1,5-benzodiazepinderivater til kontrol af mavetømning hos patienter med ikke insulinafhængig diabetes mellitus

Country Status (10)

Country Link
EP (1) EP0785787B1 (da)
JP (1) JPH10511931A (da)
AT (1) ATE210446T1 (da)
AU (1) AU3736195A (da)
DE (1) DE69524622T2 (da)
DK (1) DK0785787T3 (da)
ES (1) ES2166406T3 (da)
GB (1) GB9420747D0 (da)
PT (1) PT785787E (da)
WO (1) WO1996011691A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750353A (en) * 1995-12-11 1998-05-12 New England Medical Center Hospitals, Inc. Assay for non-peptide agonists to peptide hormone receptors
IL124808A0 (en) 1995-12-11 1999-01-26 New England Medical Center Inc Assay for and uses of peptide hormone receptor ligands
CA2347938A1 (en) * 1998-10-20 2000-04-27 Takahiro Matsumoto 1,5-benzodiazepine compounds, their production and use
US9815850B2 (en) 2016-02-05 2017-11-14 Denali Therapeutics Inc. Compounds, compositions and methods
PL3552017T3 (pl) 2016-12-09 2022-08-08 Denali Therapeutics Inc. Związki użyteczne jako inhibitory RIPK1
WO2021071837A1 (en) 2019-10-07 2021-04-15 Kallyope, Inc. Gpr119 agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187154A (en) * 1990-12-13 1993-02-16 Board Of Regents, The University Of Texas System Diagnosis and treatment of humans with diabetes or at risk to develop diabetes
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
GB9420747D0 (en) 1994-11-30
ES2166406T3 (es) 2002-04-16
WO1996011691A1 (en) 1996-04-25
DE69524622D1 (de) 2002-01-24
PT785787E (pt) 2002-04-29
DE69524622T2 (de) 2002-08-08
AU3736195A (en) 1996-05-06
JPH10511931A (ja) 1998-11-17
EP0785787A1 (en) 1997-07-30
EP0785787B1 (en) 2001-12-12
ATE210446T1 (de) 2001-12-15

Similar Documents

Publication Publication Date Title
NZ515902A (en) Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, and type 2 diabetes
WO2001012187A3 (en) Benzoic acid derivatives and their use as ppar receptor agonists
MX9700763A (es) Procedimiento para la preparacion de benzoxazoles y derivados de piridinas utiles en el tratamiento de la diabetes del tipo ii, los benzoxazoles y derivados de piridina obtenidos, composiciones de los mismos y su uso.
HUP0102074A3 (en) A medical apparatus for use by a patient for medical self treatment of diabetes
TNSN00206A1 (en) Method for treating diabetes
IS2793B (is) Notkun á 3-hýdroxý-3-metýlglútarýl hjálparensíms A afsýringarkljúfshindrum til framleiðslunnar á lyfi til að meðhöndla sykursýkitaugakvilla
NO20020968D0 (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
ZA845620B (en) Novel insulin derivatives,processes for their preparation and their use,and pharmaceutical agents for the treatment of diabetes mellitus
CA2258949A1 (en) Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
ZA975866B (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases.
MY142551A (en) Substituted diaryl heterocycles, process for their preparation and their use as medicaments
WO1996015784A3 (de) 2,2-dichloralkancarbonsäuren, verfahren zu ihrer herstellung diese enthaltende arzneimittel, und ihre verwendung zur behandlung der insulinresistenz
WO2003028715A3 (en) Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis
WO1991005538A3 (en) Thiazolidine derivatives for the treatment of hypertension
ATE89547T1 (de) Dopamin-vorlaeufer.
NZ516290A (en) Substituted phenoxyacetic acids
DK0785787T3 (da) Anvendelse af 1,5-benzodiazepinderivater til kontrol af mavetømning hos patienter med ikke insulinafhængig diabetes mellitus
AU7077096A (en) Selective beta 3 adrenergic agonists
NZ332105A (en) Medicaments including human growth hormone for the treatment of type II diabetes and metabolic syndrome
MY115466A (en) Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents and medicaments comprising them.
AU655958B2 (en) Use of quisqualate-receptor antagonists for treating Parkinson's disease
KR930701170A (ko) 항당뇨병약품
DE69007065T2 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
EA199900881A1 (ru) Терапевтическое средство против сахарного диабета
EP1121932A4 (en) DRUGS FOR EYE DISEASES